HIV-associated Cardiovascular Disease

International specialists examine therapeutic choices for the treatment of myocardial cell dysfunction in HIV disease, with a focus on knowledge in both clinical and biological aspects of HIV-associated cardiovascular disease. Topics covered include research findings from experimental work on transgenic mice; the role of cytokines in the development of HIV-associated cardiomyopathy and pulmonary hypertension (with related diagnostic and therapeutic implications); and the relationship between dilated cardiomyopathy and encephalopathy in HIV-infected adults and children.